Amgen (AMGN)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-07 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AMGEN INC (AMGN) CIK: 0000318154 --- Reporting Owner --- Name: Drake Michael V CIK: 0001938942 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-07 | Code: A (Grant or award) Shares: +63.8764 | Price: $0.00 Shares Owned After: 5,876.1633 | Ownership: D (Direct) Footnotes: [F1] These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. --- Footnotes (Complete Index) --- F1: These shares include 377 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. --- Signature --- /s/ /s/ Michael V. Drake (2026-08-10)